Metabolic syndrome (MetS) is a cluster of cardiovascular risk factors which severely
increases the risk of type II diabetes and cardiovascular disease. Several epidemiological …

Dietary polyphenols constitute a large family of bioactive substances potential beneficial
effect on metabolic syndrome (MetS). This review summarizes the results of clinical studies …

Metabolic syndrome (MS) is the term for a combination of hypertension, dyslipidemia, insulin
resistance, and central obesity as factors leading to cardiovascular and metabolic disease …

Purpose The aim of this study was to evaluate the association between total and individual
classes and subclasses of dietary polyphenol intake and prevalence of metabolic syndrome …

Dietary polyphenol intake is associated with improvement of metabolic disturbances. The
aims of the present study are to describe dietary polyphenol intake in a population with …

Metabolic syndrome (MetS) is defined as the co‐occurrence of metabolic risk factors that
includes insulin resistance, hyperinsulinemia, impaired glucose tolerance, type 2 diabetes …

Background Polyphenols may lower the risk of cardiovascular disease (CVD) and other
chronic diseases due to their antioxidant and anti-inflammatory properties, as well as their …

Type 2 diabetes is an increasing health concern worldwide. Both genetic and environmental
risk factors as improper dietary habits or physical inactivity are known to be crucial in the …

Polyphenols are common constituents of the diet, and research on their health benefits has
developed quickly over the past few years. Our purpose is to review recent findings …

Future intervention studies should include a detailed assessment of the bioavailability of
polyphenols. Beyond clinical trials carried out with polyphenol-rich foods, more studies with …